Europe’s Early-Stage Life Sciences Venture Capitalists Unveil Advocacy Organisation to Drive Innovation and Investment in Health Care

Robert Marcus
Oct 4, 2021

Related news

Dec 16
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AI drug discovery platform raises Series B funding

Oct 25
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Artificial Intelligence Is Transforming Biotechnology, Especially When It Comes To Innovations In Nitric Oxide

Sep 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Exscientia Files For $100M IPO

Sep 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Exscientia Files For $100M IPO

Oct 16
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

The 2021 machine learning, AI, and data landscape

Nov 24
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Family Offices Become Serious Rivals to VC Firms

Dec 22
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Deloitte reports biopharma prioritizes AI investment

Nov 24
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

EU New Role as Tech Venture Capitalist

Oct 4
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Europe’s Early-Stage Life Sciences Venture Capitalists Unveil Advocacy Organisation to Drive Innovation and Investment in Health Care

Feb 1
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding

Mar 2
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Innovative AI-powered Search and Discovery Platform; Interview With Robert Marcus